Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
JANSSEN PHARMACEUTICALS, INC. et al v. TEVA PHARMACEUTICALS USA, INC. et al
Case Number:
2:18-cv-00734
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
35:271 Patent Infringement
Judge:
Firms
Companies
Sectors & Industries:
-
April 01, 2024
Fed. Circ. Revives Challenges To J&J Schizophrenia Drug
A Federal Circuit panel on Monday gave generics-makers Teva Pharmaceuticals USA Inc. and Viatris Inc. a new chance to prove that a patent on Johnson & Johnson's blockbuster schizophrenia drug Invega Sustenna is invalid, saying a lower court used an "erroneously rigid" analysis when rejecting their challenge.
-
June 10, 2021
Teva Gets Judge To Nix Drug IP Inventorship Correction Order
A New Jersey federal judge took the unusual step of reversing an order telling the U.S. Patent and Trademark Office to add two inventors to a Janssen Pharmaceuticals Inc. patent after its rival Teva informed the court that it had never consented to the inventors' addition.
-
January 18, 2018
Janssen Sues Teva To Stop Generic Of Schizophrenia Drug
A generic version of the schizophrenia drug Invega Sustenna that Teva Pharmaceuticals seeks to manufacture and sell would infringe the asserted claims of a patent covering the drug, Janssen Pharmaceuticals Inc. alleged Wednesday in New Jersey federal court.